Engheta Arman, Hadadi Abianeh Shahryar, Atri Ali, Sanatkarfar Mehdi
Department of Plastic Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Plastic Surgery, Razi Hospital, Tehran University of Medical Sciences, Vahdat Eslami st, Tehran, Iran.
Daru. 2016 Jul 28;24(1):20. doi: 10.1186/s40199-016-0159-4.
ᅟ: We investigated the occurrence of bleeding complications in patients who underwent skin tumor surgery and compared it between Aspirin users and a placebo control group. In this double blind randomized controlled trial, 32 patients who continued taking aspirin (intervention group) and 38 patients who stopped taking Aspirin (placebo group) before surgery were compared in terms of intraoprative and postoperative bleeding problems, hematoma and local signs of coagulopathy. There was no statistically significant difference in intraoprative bleeding between the study groups (P = 0.107). We concluded that continuation of Aspirin therapy had no significant effect on bleeding complications in patients who underwent skin tumor surgery.
IRCT201602049768N5 Flow chart of the study process and its final finding.
我们调查了接受皮肤肿瘤手术患者出血并发症的发生率,并在阿司匹林使用者和安慰剂对照组之间进行了比较。在这项双盲随机对照试验中,比较了32名术前继续服用阿司匹林的患者(干预组)和38名术前停用阿司匹林的患者(安慰剂组)在术中及术后的出血问题、血肿和凝血障碍的局部体征。研究组之间术中出血无统计学显著差异(P = 0.107)。我们得出结论,继续使用阿司匹林治疗对接受皮肤肿瘤手术患者的出血并发症无显著影响。
IRCT201602049768N5 研究过程及其最终结果的流程图。